AbrahamN.,
StojdlD. F.,
DuncanP. I.,
MethotN.,
IshiiT.,
DubeM.,
VanderhydenB. C.,
AtkinsH. L.,
GrayD. A.,
McBurneyM. W.,
KoromilasA. E.,
BrownE. G.,
SonenbergN.,
BellJ. C.1999; Characterization of transgenic mice with targeted disruption of the catalytic domain of the double-stranded RNA-dependent protein kinase, PKR. Journal of Biological Chemistry 274:5953–5962
ArenaA.,
LibertoM. C.,
IannelloD.,
CapozzaA. B.,
FocaA.1999; Altered cytokine production after human herpes virus type 6 infection. New Microbiologica 22:293–300
ArnheiterH.,
FreseM.,
KamadurR.,
MeierE.,
HallerO.1995; Mx transgenic mice – animal models of health. Current Topics in Microbiology and Immunology 206:119–147
AuW. C.,
MooreP. A.,
LaFleurD. W.,
TombalB.,
PithaP. M.1998; Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes. Journal of Biological Chemistry 273:29210–29217
AuneT. M.,
PenixL. A.,
RinconM. R.,
FlavellR. A.1997; Differential transcription directed by discrete gamma interferon promoter elements in naive and memory (effector) CD4 T cells and CD8 T cells. Molecular and Cellular Biology 17:199–208
BachE. A.,
TannerJ. W.,
MarstersS.,
AshkenaziA.,
AguetM.,
ShawA. S.,
SchreiberR. D.1996; Ligand-induced assembly and activation of the gamma interferon receptor in intact cells. Molecular and Cellular Biology 16:3214–3221
BalachandranS.,
KimC. N.,
YehW. C.,
MakT. W.,
BhallaK.,
BarberG. N.1998; Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO Journal 17:6888–6902
BalachandranS.,
RobertsP. C.,
KippermanT.,
BhallaK. N.,
CompansR. W.,
ArcherD. R.,
BarberG. N.2000; Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/caspase-8 death signaling pathway. Journal of Virology 74:1513–1523
BassB. L.,
WeintraubH.,
CattaneoR.,
BilleterM. A.1989; Biased hypermutation of viral RNA genomes could be due to unwinding/modification of double-stranded RNA. Cell 56:331–335
BergeronJ.,
MabroukT.,
GarzonS.,
LemayG.1998; Characterization of the thermosensitive ts453 reovirus mutant: increased dsRNA binding of sigma 3 protein correlates with interferon resistance. Virology 246:199–210
BhatR. A.,
ThimmappayaB.1985; Construction and analysis of additional adenovirus substitution mutants confirm the complementation of VAI RNA function by two small RNAs encoded by Epstein–Barr virus. Journal of Virology 56:750–756
BhattacharyaS.,
EcknerR.,
GrossmanS.,
OldreadE.,
AranyZ.,
D’AndreaA.,
LivingstonD. M.1996; Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α. Nature 383:344–347
BironC. A.,
NguyenK. B.,
PienG. C.,
CousensL. P.,
Salazar-MatherT. P.1999; Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annual Review of Immunology 17:189–220
BlackT. L.,
SaferB.,
HovanessianA.,
KatzeM. G.1989; The cellular 68,000- M r protein kinase is highly autophosphorylated and activated yet significantly degraded during poliovirus infection: implications for translational regulation. Journal of Virology 63:2244–2251
BlackT. L.,
BarberG. N.,
KatzeM. G.1993; Degradation of the interferon-induced 68,000- M r protein kinase by poliovirus requires RNA. Journal of Virology 67:791–800
BovolentaC.,
LoriniA. L.,
MantelliB.,
CamoraliL.,
NovelliF.,
BiswasP.,
PoliG.1999; A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1. Journal of Immunology 162:323–330
BrandS. R.,
KobayashiR.,
MathewsM. B.1997; The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKR. Journal of Biological Chemistry 272:8388–8395
BriscoeJ.,
RogersN. C.,
WitthuhnB. A.,
WatlingD.,
HarpurA. G.,
WilksA. F.,
StarkG. R.,
IhleJ. N.,
KerrI. M.1996; Kinase-negative mutants of JAK1 can sustain interferon-gamma-inducible gene expression but not an antiviral state. EMBO Journal 15:799–809
BuchmeierN. A.,
SchreiberR. D.1985; Requirement of endogenous interferon-gamma production for resolution of Listeria monocytogenes infection. Proceedings of the National Academy of Sciences, USA 82:7404–7408
BuschleM.,
CampanaD.,
CardingS. R.,
RichardC.,
HoffbrandA. V.,
BrennerM. K.1993; Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. Journal of Experimental Medicine 177:213–218
CaiR.,
CarpickB.,
ChunR. F.,
JeangK. T.,
WilliamsB. R.2000; HIV-I TAT inhibits PKR activity by both RNA-dependent and RNA-independent mechanisms. Archives of Biochemistry and Biophysics 373:361–367
CantinE.,
TanamachiB.,
OpenshawH.,
MannJ.,
ClarkeK.1999; Gamma interferon (type II IFN) receptor null-mutant mice are more susceptible to herpes simplex virus type 1 infection than type II IFN ligand null-mutant mice. Journal of Virology 73:5196–5200
CassadyK. A.,
GrossM.,
RoizmanB.1998; The second-site mutation in the herpes simplex virus recombinants lacking the γ134.5 genes precludes shutoff of protein synthesis by blocking the phosphorylation of eIF-2α. Journal of Virology 72:7005–7011
CastelliJ. C.,
HasselB. A.,
MaranA.,
ParanjapeJ.,
HewittJ. A.,
LiX. L.,
HsuY. T.,
SilvermanR. H.,
YouleR. J.1998a; The role of 2′–5′ oligoadenylate-activated ribonuclease L in apoptosis. Cell Death and Differentiation 5:313–320
CayleyP. J.,
KnightM.,
KerrI. M.1982; Virus-mediated inhibition of the ppp(A2′p)nA system and its prevention by interferon. Biochemical and Biophysical Research Communications 104:376–382
CayleyP. J.,
DaviesJ. A.,
McCullaghK. G.,
KerrI. M.1984; Activation of the ppp(A2′p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2′p)nA-dependent RNase. European Journal of Biochemistry 15:165–174
ChangH. W.,
WatsonJ. L.,
JacobsB. L.1992; The E3L gene of vaccinia virus encodes an inhibitor of PKR. Proceedings of the National Academy of Sciences USA: 89:4825–4829
Chatterjee-KishoreM.,
KishoreR.,
HicklinD. J.,
MarincolaF. M.,
FerroneS.1998; Different requirements for signal transducer and activator of transcription 1α and interferon regulatory factor 1 in the regulation of low molecular mass polypeptide 2 and transporter associated with antigen processing 1 gene expression. Journal of Biological Chemistry 273:16177–16183
ChenZ.,
LiY.,
KrugR. M.1999; Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3′-end processing machinery. EMBO Journal 18:2273–2283
ChinY. E.,
KitagawaM.,
KuidaK.,
FlavellR. A.,
FuX.-Y.1997; Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Molecular and Cellular Biology 17:5328–5337
ChinsangaramJ.,
PicconeM. E.,
GrubmanM. J.1999; Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. Journal of Virology 73:9891–9898
ChoubeyD.,
LengyelP.1995; Binding of an interferon-inducible protein (p202) to the retinoblastoma protein. Journal of Biological Chemistry 270:6134–6140
ChuW. M.,
OstertagD.,
LiZ. W.,
ChangL.,
ChenY.,
HuY.,
WilliamsB.,
PerraultJ.,
KarinM.1999; JNK2 and IKKβ are required for activating the innate response to viral infection. Immunity 11:721–731
ClemensM. J.,
EliaA.1997; The double-stranded RNA-dependent protein kinase PKR: structure and function. Journal of Interferon and Cytokine Research 17:503–524
ColamoniciO.,
YanH.,
DomanskiP.,
HandaR.,
SmalleyD.,
MullersmanJ.,
WitteM.,
KrishnanK.,
KrolewskiJ.1994; Direct binding and tyrosine phosphorylation of the α-subunit of the type I IFN receptor by the p135tyk2 tyrosine kinase. Molecular and Cellular Biology 14:8133–8142
ColamoniciO. R.,
DomanskiP.,
SweitzerS. M.,
LarnerA.,
BullerR. M. L.1995; Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon α transmembrane signaling. Journal of Biological Chemistry 270:15974–15978
CousensL. P.,
PetersonR.,
HsuS.,
DornerA.,
AltmanJ. D.,
AhmedR.,
BironC. A.1999; Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection. Journal of Experimental Medicine 189:1315–1328
CuddihyA. R.,
LiS.,
TamN. W.,
WongA. H.,
TayaY.,
AbrahamN.,
BellJ. C.,
KoromilasA. E.1999a; Double-stranded-RNA-activated protein kinase PKR enhances transcriptional activation by tumor suppressor p53. Molecular and Cellular Biology 19:2475–2484
CuddihyA. R.,
WongA. H.,
TamN. W.,
LiS.,
KoromilasA. E.1999b; The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro. Oncogene 18:2690–2702
DaltonD. K.,
Pitts-MeekS.,
KeshavS.,
FigariI. S.,
BradleyA.,
StewartT. A.1993; Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259:1739–1742
DavidM.,
ZhouG.,
PineR.,
DixonJ. E.,
LarnerA. C.1996; The SH2 domain-containing tyrosine phosphatase PTP1D is required for interferon alpha/beta-induced gene expression. Journal of Biological Chemistry 271:15862–15865
DaviesM. V.,
Elroy-SteinO.,
JagusR.,
MossB.,
KaufmanR. J.1992; The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2. Journal of Virology 66:1943–1950
DaviesM. V.,
ChangH.-W.,
JacobsB. L.,
KaufmanR. J.1993; The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms. Journal of Virology 67:1688–1692
DerS. D.,
YangY.-L.,
WeissmannC.,
WilliamsB. R. G.1997; A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proceedings of the National Academy of Sciences, USA 94:3279–3283
DerS. D.,
ZhouA.,
WilliamsB. R.,
SilvermanR. H.1998; Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proceedings of the National Academy of Sciences, USA 95:15623–15628
DesaiS. Y.,
PatelR. C.,
SenG. C.,
MalhotraP.,
GhadgeG. D.,
ThimmapayaB.1995; Activation of interferon-inducible 2′–5′ oligoadenylate synthetase by adenoviral VAI RNA. Journal of Biological Chemistry 270:3454–3461
DeverT. E.,
ChenJ. J.,
BarberJ. N.,
CiganA. M.,
FengL.,
DonahueT. F.,
LondonI. M.,
KatzeM. G.,
HinnebuschA. G.1993; Mammalian eukaryotic initiation 2α kinase functionally substitutes for GCN 2 protein kinase in the GCN 4 translational control mechanism of yeast. Proceedings of the National Academy of Sciences, USA 90:4616–4620
DeverT. E.,
SripriyaR.,
McLachlinJ. R.,
LuJ.,
Fabian-MatcherJ. R.,
KimballS. R.,
MillerL. K.1998; Disruption of cellular translational control by a viral truncated eukaryotic translation initiation factor 2α kinase homolog. Proceedings of the National Academy of Sciences, USA 95:4164–4169
DidcockL.,
YoungD. F.,
GoodbournS.,
RandallR. E.1999b; The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. Journal of Virology 73:9928–9933
EndoT. A.,
MasuharaM.,
YokouchiM.,
SuzukiR.,
SakamotoH.,
MitsuiK.,
MatsumotoA.,
TanimuraS.,
OhtsuboM.,
MisawaH.,
MiyazakiT.,
LeonorN.,
TaniguchiT.,
FujitaT.,
KanakuraY.,
KomiyaS.,
YoshimuraA.1997; A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921–924
EppersonD. E.,
ArnoldD.,
SpiesT.,
CresswellP.,
PoberJ. S.,
JohnsonD. R.1992; Cytokines increase transporter in antigen processing-1 expression more rapidly than HLA class I expression in endothelial cells. Journal of Immunology 149:3297–3301
ErlandssonL.,
BlumenthalR.,
ElorantaM. L.,
EngelH.,
AlmG.,
WeissS.,
LeandersonT.1998; Interferon-beta is required for interferon-alpha production in mouse fibroblasts. Current Biology 8:223–226
FawazL. M.,
Sharif-AskariE.,
MenezesJ.1999; Up-regulation of NK cytotoxic activity via IL-15 induction by different viruses: a comparative study. Journal of Immunology 163:4473–4480
FehnigerT. A.,
ShahM. H.,
TurnerM. J.,
VanDeusenJ. B.,
WhitmanS. P.,
CooperM. A.,
SuzukiK.,
WechserM.,
GoodsaidF.,
CaligiuriM. A.1999; Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. Journal of Immunology 162:4511–4520
FerranM. C.,
Lucas-LenardJ. M.1997; The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter. Journal of Virology 71:371–377
FietteL.,
AubertC.,
MullerU.,
HuangS.,
AguetM.,
BrahicM.,
BureauJ. F.1995; Theiler’s virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors. Journal of Experimental Medicine 181:2069–2076
FlatiV.,
HaqueS. J.,
WilliamsB. R.1996; Interferon-alpha-induced phosphorylation and activation of cytosolic phospholipase A2 is required for the formation of interferon-stimulated gene factor three. EMBO Journal 15:1566–1571
FleschI. E.,
HessJ. H.,
HuangS.,
AguetM.,
RotheJ.,
BluethmannH.,
KaufmannS. H.1995; Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha. Journal of Experimental Medicine 181:1615–1621
FossG. S.,
PrydzH.1999; Interferon regulatory factor 1 mediates the interferon-gamma induction of the human immunoproteasome subunit multicatalytic endopeptidase complex-like 1. Journal of Biological Chemistry 274:35196–35202
FreseM.,
KochsG.,
Meier-DieterU.,
SieblerJ.,
HallerO.1995; Human MxA protein inhibits tick-borne Thogoto virus but not Dhori virus. Journal of Virology 69:3904–3909
FreseM.,
KochsG.,
FeldmannH.,
HertkornC.,
HallerO.1996; Inhibition of bunyaviruses, phleboviruses and hantaviruses by human MxA protein. Journal of Virology 70:915–923
FreseM.,
WeeberM.,
WeberF.,
SpethV.,
HallerO.1997; Mx1 sensitivity: Batken virus is an orthomyxovirus closely related to Dhori virus. Journal of General Virology 78:2453–2458
FriedmanR. L.,
ManlyS. P.,
McMahonM.,
KerrI. M.,
StarkG. R.1984; Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell 38:745–755
FujimotoI.,
TakizawaT.,
OhbaY.,
NakanishiY.1998; Co-expression of Fas and Fas-ligand on the surface of influenza virus-infected cells. Cell Death and Differentiation 5:426–431
FujitaT.,
ReisL. F.,
WatanabeN.,
KimuraY.,
TaniguchiT.,
VilcekJ.1989b; Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways. Proceedings of the National Academy of Sciences, USA 86:9936–9940
FurukawaY.,
IwaseS.,
KikuchiJ.,
NakamuraM.,
YamadaH.,
MatsudaM.1999; Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes. Oncogene 18:2003–2014
GajewskiT. F.,
FitchF. W.1988; Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. Journal of Immunology 140:4245–4252
GaleM.Jr,
KatzeM. G.1998; Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacology & Therapeutics 78:29–46
GaleM. J.Jr,
KorthM. J.,
TangN. M.,
TanS.-L.,
HopkinsD. A.,
DeverT. E.,
PolyakS. J.,
GretchD. R.,
KatzeM. G.1997; Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230:217–227
Garcia-SastreA.,
DurbinR. K.,
ZhengH.,
PaleseP.,
GertnerR.,
LevyD. E.,
DurbinJ. E.1998; The role of interferon in influenza virus tissue tropism. Journal of Virology 72:8550–8558
GarcinD.,
LatorreP.,
KolakofskyD.1999; Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state. Journal of Virology 73:6559–6565
GartelA. L.,
SerfasM. S.,
TynerA. L.1996; p21 – negative regulator of the cell cycle. Proceedings of the Society for Experimental Biology and Medicine 213:138–149
GeorgeC. X.,
ThomisD. C.,
McCormackS. J.,
SvahnC. M.,
SamuelC. E.1996; Characterization of the heparin-mediated activation of PKR, the interferon-inducible RNA-dependent protein kinase. Virology 221:180–188
GilJ.,
AlcamiJ.,
EstebanM.1999; Induction of apoptosis by double-stranded-RNA-dependent protein kinase (PKR) involves the alpha subunit of eukaryotic translation initiation factor 2 and NF-kappaB. Molecular and Cellular Biology 19:4653–4663
GoatleyL. C.,
MarronM. B.,
JacobsS. C.,
HammondJ. M.,
MiskinJ. E.,
AbramsC. C.,
SmithG. L.,
DixonL. K.1999; Nuclear and nucleolar localization of an African swine fever virus protein, I14L, that is similar to the herpes simplex virus-encoded virulence factor ICP34.5. Journal of General Virology 80:525–535
GotohB.,
TakeuchiK.,
KomatsuT.,
YokooJ.,
KimuraY.,
KurotaniA.,
KatoA.,
NagaiY.1999; Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon-alpha/beta-mediated responses. FEBS Letters 459:205–210
GrawunderU.,
MelchersF.,
RolinkA.1993; Interferon-gamma arrests proliferation and causes apoptosis in stromal cell/interleukin-7-dependent normal murine pre-B cell lines and clones in vitro, but does not induce differentiation to surface immunoglobulin-positive B cells. European Journal of Immunology 23:544–551
GreenlundA. C.,
FarrarM. A.,
VivianoB. L.,
SchreiberR. D.1994; Ligand-induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). EMBO Journal 13:1591–1600
GriederF. B.,
VogelS. N.1999; Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection. Virology 257:106–118
GrobP.,
SchijnsV. E.,
van den BroekM. F.,
CoxS. P.,
AckermannM.,
SuterM.1999; Role of the individual interferon systems and specific immunity in mice in controlling systemic dissemination of attenuated pseudorabies virus infection. Journal of Virology 73:4748–4754
GunneryS.,
RiceA. P.,
RobertsonH. D.,
MathewsM. B.1990; Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase. Proceedings of the National Academy of Sciences, USA 87:8687–8691
GuttermanJ. U.,
ChoubeyD.1999; Retardation of cell proliferation after expression of p202 accompanies an increase in p21(WAF1/CIP1. Cell Growth & Differentiation 10:93–100
HaigD. M.,
McInnesC. J.,
ThomsonJ.,
WoodA.,
BunyanK.,
MercerA.1998; The orf virus OV20.0L gene product is involved in interferon resistance and inhibits an interferon-inducible, double-stranded RNA-dependent kinase. Immunology 93:335–340
HallerO.,
FreseM.,
RostD.,
NuttallP. A.,
KochsG.1995; Tick-borne Thogoto virus infection in mice is inhibited by the orthomyxovirus resistance gene product Mx1. Journal of Virology 69:2596–2601
HaqueS. J.,
WilliamsB. R.1994; Identification and characterization of an interferon (IFN)-stimulated response element–IFN-stimulated gene factor 3-independent signaling pathway for IFN-alpha. Journal of Biological Chemistry 269:19523–19529
HaradaH.,
FujitaT.,
MiyamotoM.,
KimuraY.,
MaruyamaM.,
FuriaA.,
MiyataT.,
TaniguchiT.1989; Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58:729–739
HarperJ. W.,
AdamiG. R.,
WeiN.,
KeyomarsiK.,
ElledgeS. J.1993; The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805–816
HarrochS.,
RevelM.,
ChebathJ.1994; Induction by interleukin-6 of interferon regulatory factor 1 (IRF-1) gene expression through the palindromic interferon response element pIRE and cell type-dependent control of IRF-1 binding to DNA. EMBO Journal 13:1942–1949
HasselB. A.,
ZhouA.,
SotomayorC.,
MaranA.,
SilvermanR. H.1993; A dominant negative mutant of 2–5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO Journal 12:3297–3304
HatadaE.,
SaitoS.,
FukudaR.1999; Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells. Virology 73:2425–2433
HeB.,
GrossM.,
RoizmanB.1997; The γ134.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1a to dephosphorylate the α subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proceedings of the National Academy of Sciences USA: 94:843–848
HeftiH. P.,
FreseM.,
LandisH.,
Di PaoloC.,
AguzziA.,
HallerO.,
PavlovicJ.1999; Human MxA protein protects mice lacking a functional alpha/beta interferon system against La crosse virus and other lethal viral infections. Journal of Virology 73:6984–6991
HeimM. H.,
KerrI. M.,
StarkG. R.,
DarnellJ. E.Jr1995; Contribution of STAT SH2 groups to specific interferon signaling by the Jak–STAT pathway. Science 267:1347–1349
HeimM. H.,
MoradpurD.,
BlumH. E.1999; Expression of hepatitis C virus proteins inhibits signal transduction through the Jak–STAT pathway. Journal of Virology 73:8469–8475
HendersonY. C.,
ChouM.,
DeisserothA. B.1997; Interferon regulatory factor 1 induces the expression of the interferon-stimulated genes. British Journal of Haematology 96:566–575
HsiehC. S.,
MacatoniaS. E.,
TrippC. S.,
WolfS. F.,
O’GarraA.,
MurphyK. M.1993; Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547–549
HsuD. H.,
de Waal MalefytR.,
FiorentinoD. F.,
DangM. N.,
VieiraP.,
de VriesJ.,
SpitsH.,
MosmannT. R.,
MooreK. W.1990; Expression of interleukin-10 activity by Epstein–Barr virus protein BCRF1. Science 250:830–832
HwangS. Y.,
HertzogP. J.,
HollandK. A.,
SumarsonoS. H.,
TymmsM. J.,
HamiltonJ. A.,
WhittyG.,
BertoncelloI.,
KolaI.1995; A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proceedings of the National Academy of Sciences, USA 92:11284–11288
IgarashiK.,
DavidM.,
LarnerA. C.,
FinbloomD. S.1993; In vitro activation of a transcription factor by gamma interferon requires a membrane-associated tyrosine kinase and is mimicked by vanadate. Molecular and Cellular Biology 13:3984–3989
IgarashiK.,
GarottaG.,
OzmenL.,
ZiemieckiA.,
WilksA. F.,
HarpurA. G.,
LarnerA. C.,
FinbloomD. S.1994; Interferon-gamma induces tyrosine phosphorylation of interferon-gamma receptor and regulated association of protein tyrosine kinases, Jak1 and Jak2, with its receptor. Journal of Biological Chemistry 269:14333–14336
IordanovM. S.,
ParanjapeJ. M.,
ZhouA.,
WongJ.,
WilliamsB. R.,
MeursE. F.,
SilvermanR. H.,
MagunB. E.2000; Activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways. Molecular and Cellular Biology 20:617–627
IwaseS.,
FurukawaY.,
KikuchiJ.,
NagaiM.,
TeruiY.,
NakamuraM.,
YamadaH.1997; Modulation of E2F activity is linked to interferon-induced growth suppression of hematopoietic cells. Journal of Biological Chemistry 272:12406–12414
JacobsB. L.,
LanglandJ. O.1996; When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 219:339–349
JacobsB. L.,
LanglandJ. O.1998; Reovirus sigma 3 protein: dsRNA binding and inhibition of RNA-activated protein kinase. Current Topics in Microbiology and Immunology 233:185–196
JaramilloM. L.,
AbrahamN.,
BellJ. C.1995; The interferon system: a review with emphasis on the role of PKR in growth control. Cancer Investigations 13:327–338
JohnstoneR. W.,
KerryJ. A.,
TrapaniJ. A.1998; The human interferon-inducible protein, IFI 16, is a repressor of transcription. Journal of Biological Chemistry 273:17172–17177
KandaK.,
DeckerT.,
AmanP.,
WahlstromM.,
von GabainA.,
KallinB.1992; The EBNA2-related resistance towards α interferon (IFN-α) in Burkitt’s lymphoma cells effects induction of IFN-induced genes but not the activation of transcription factor ISGF-3. Molecular and Cellular Biology 12:4930–4936
KanoA.,
HaruyamaT.,
AkaikeT.,
WatanabeY.1999; IRF-1 is an essential mediator in IFN-gamma-induced cell cycle arrest and apoptosis of primary cultured hepatocytes. Biochemical and Biophysical Research Communications 257:672–677
KaserA.,
EnrichB.,
LudwiczekO.,
VogelW.,
TilgH.1999; Interferon-α (IFN-α) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathway. Clinical and Experimental Immunology 118:71–77
KatzeM. G.,
WambachM.,
WongM. L.,
GarfinkelM.,
MeursE.,
ChongK.,
WilliamsB. R.,
HovanessianA. G.,
BarberG. N.1991; Functional expression and RNA binding analysis of the interferon-induced, double-stranded RNA-activated, 68,000- M r protein kinase in a cell-free system. Molecular and Cellular Biology 11:5497–5505
KerrI. M.,
BrownR. E.1978; pppA2′p5′A2′p5′A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proceedings of the National Academy of Sciences, USA 75:256–260
KimuraT.,
NakayamaK.,
PenningerJ.,
KitagawaM.,
HaradaH.,
MatsuyamaT.,
TanakaN.,
KamijoR.,
VilcekJ.,
MakT. W.,
TaniguchiT.1994; Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science 264:1921–1924
KingsmoreS. F.,
SnoddyJ.,
ChoubeyD.,
LengyelP.,
SeldinM. F.1989; Physical mapping of a family of interferon-activated genes, serum amyloid P-component, and alpha-spectrin on mouse chromosome 1. Immunogenetics 30:169–174
KirchH. C.,
PutzerB.,
BrockmannD.,
EscheH.,
KlokeO.1997; Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in interferon-alpha-resistant U937VR cells. European Journal of Biochemistry 246:736–744
KomatsuT.,
TakeuchiK.,
YokooJ.,
TanakaY.,
GotohB.2000; Sendai virus blocks alpha interferon signaling to signal transducers and activators of transcription. Journal of Virology 74:2477–2480
KoromilasA. E.,
RoyS.,
BarberG. N.,
KatzeM. G.,
SonenbergN.1992; Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 257:1685–1689
KotenkoS. V.,
IzotovaL. S.,
PollackB. P.,
MarianoT. M.,
DonnellyR. J.,
MuthukumaranG.,
CookJ. R.,
GarottaG.,
SilvennoinenO.,
IhleJ. N.,
KerrI.1995; Interaction between the components of the interferon gamma receptor complex. Journal of Biological Chemistry 270:20915–20921
KovarikP.,
StoiberD.,
EyersP. A.,
MenghiniR.,
NeiningerA.,
GaestelM.,
CohenP.,
DeckerT.1999; Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN-gamma uses a different signaling pathway. Proceedings of the National Academy of Sciences, USA 96:13956–13961
KumarA.,
HaqueJ.,
LacosteJ.,
HiscottJ.,
WilliamsB. R. G.1994; Double-stranded RNA-dependent protein kinase activates transcription factor NF-κB by phosphorylating IκB. Proceedings of the National Academy of Sciences, USA 91:6288–6292
KumarA.,
YangY. L.,
FlatiV.,
DerS.,
KadereitS.,
DebA.,
HaqueJ.,
ReisL.,
WeissmannC.,
WilliamsB. R.1997; Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-κB. EMBO Journal 16:406–416
LandisH.,
Simon-JodickeA.,
KlotiA.,
Di PaoloC.,
SchnorrJ. J.,
Schneider-SchauliesS.,
HeftiH. P.,
PavlovicJ.1998; Human MxA protein confers resistance to Semliki Forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins. Journal of Virology 72:1516–1522
LanglandJ. O.,
PettifordS.,
JiangB.,
JacobsB. L.1994; Products of the porcine group C rotavirus NSP3 gene bind specifically to double-stranded RNA and inhibit activation of the interferon-induced protein kinase PKR. Journal of Virology 68:3821–3829
LarnerA. C.,
ChaudhuriA.,
DarnellJ. E.Jr1986; Transcriptional induction by interferon. New protein(s) determine the extent and length of the induction. Journal of Biological Chemistry 261:453–459
LechleitnerS.,
GilleJ.,
JohnsonD. R.,
PetzelbauerP.1998; Interferon enhances tumor necrosis factor-induced vascular cell adhesion molecule 1 (CD106) expression in human endothelial cells by an interferon-related factor 1-dependent pathway. Journal of Experimental Medicine 187:2023–2030
LeeT. G.,
TomitaJ.,
HovanessianA. G.,
KatzeM. G.1990; Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of M r 68,000 from influenza virus-infected cells. Proceedings of the National Academy of Sciences, USA 87:6208–6212
LeeT. G.,
TomitaJ.,
HovanessianA. G.,
KatzeM. G.1992; Characterization and regulation of the 58,000-dalton cellular inhibitor of the interferon-induced, dsRNA-activated protein kinase. Journal of Biological Chemistry 267:14238–14243
LeeT. G.,
TangN.,
ThompsonS.,
MillerJ.,
KatzeM. G.1994; The 58,000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins. Molecular and Cellular Biology 14:2331–2342
LeeS. B.,
RodriguezD.,
RodriguezJ. R.,
EstebanM.1997; The apoptosis pathway triggered by the interferon-induced protein kinase PKR requires the third basic domain, initiates upstream of Bcl-2, and involves ICE-like proteases. Virology 231:81–88
LeibD. A.,
MachalekM. A.,
WilliamsB. R. G.,
SilvermanR. H.,
VirginH. W.2000; Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proceedings of the National Academy of Sciences, USA 97:6097–6101
LemboD.,
AngerettiA.,
BenefazioS.,
HertelL.,
GariglioM.,
NovelliF.,
LandolfoS.1995; Constitutive expression of the interferon-inducible protein p202 in NIH 3T3 cells affects cell cycle progression. Journal of Biological Regulators and Homeostatic Agents 9:42–46
LenardoM. J.,
FanC.-M.,
ManiatisT.,
BaltimoreD.1989; The involvement of NF-κB in β-interferon gene regulation reveals its role as a widely inducible mediator of signal transduction. Cell 57:287–294
LeungS.,
QureshiS. A.,
KerrI. M.,
DarnellJ. E.Jr,
StarkG. R.1995; Role of STAT2 in the alpha interferon signaling pathway. Molecular and Cellular Biology 15:1312–1317
LiX.,
LeungS.,
KerrI. M.,
StarkG. R.1997; Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling. Molecular and Cellular Biology 17:2048–2056
LloydR. M.,
ShatkinA. J.1992; Translational stimulation by reovirus polypeptide sigma 3: substitution for VAI RNA and inhibition of phosphorylation of the alpha subunit of eukaryotic initiation factor 2. Journal of Virology 66:6878–6884
LookD. C.,
RoswitW. T.,
FrickA. G.,
Gris-AlevyY.,
DickhausD. M.,
WalterM. J.,
HoltzmanM. J.1998; Direct suppression of Stat1 function during adenoviral infection. Immunity 9:871–880
LuY.,
WambachM.,
KatzeM. G.,
KrugR. M.1995; Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the eIF-2 translation initiation factor. Virology 214:222–228
McMillanN. A.,
ChunR. F.,
SiderovskiD. P.,
GalabruJ.,
TooneW. M.,
SamuelC. E.,
MakT. W.,
HovanessianA. G.,
JeangK. T.,
WilliamsB. R.1995; HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. Virology 213:413–424
MaranA.,
MaitraR. K.,
KumarA.,
DongB.,
XiaoW.,
LiG.,
WilliamsB. R.,
TorrenceP. F.,
SilvermanR. H.1994; Blockage of NF-kappa B signaling by selective ablation of an mRNA target by 2–5A antisense chimeras. Science 265:789–792
MartinandC.,
SalehzadaT.,
SilholM.,
LebleuB.,
BisbalC.1998; RNase L inhibitor (RLI) antisense constructions block partially the down regulation of the 2–5A/RNase L pathway in encephalomyocarditis-virus-(EMCV)-infected cells. European Journal of Biochemistry 254:248–255
MartinandC.,
MontavonC.,
SalehzadaT.,
SilholM.,
LebleuB.,
BisbalC.1999; RNase L inhibitor induced during human immunodeficiency virus type 1 infection and down regulates the 2–5A/RNase L pathway in human T cells. Journal of Virology 73:290–296
Martinez-CostasJ.,
Gonzalez-LopezC.,
VakhariaV. N.,
BenaventeJ.2000; Possible involvement of the double-stranded RNA-binding core protein σA in the resistance of avian reovirus to interferon. Journal of Virology 74:1124–1131
MelvilleM. W.,
HansenW. J.,
FreemanB. C.,
WelchW. J.,
KatzeM. G.1997; The molecular chaperone hsp40 regulates the activity of P58IPK, the cellular inhibitor of PKR. Proceedings of the National Academy of Sciences, USA 94:97–102
MeursE.,
ChongK.,
GalabruJ.,
ThomasN. S.,
KerrI. M.,
WilliamsB. R.,
HovanessianA. G.1990; Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62:379–390
MillerD. M.,
RahillB. M.,
BossJ. M.,
LairmoreM. D.,
DurbinJ. E.,
WaldmanJ. W.,
SedmakD. D.1998; Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/STAT pathway. Journal of Experimental Medicine 187:675–683
MillerD. M.,
ZhangY.,
RahillB. M.,
WaldmanW. J.,
SedmakD. D.1999; Human cytomegalovirus inhibits IFN-α-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-α signal transduction. Journal of Immunology 162:6107–6113
MogensenK. E.,
LewerenzM.,
ReboulJ.,
LutfallaG.,
UzeG.1999; The type I interferon receptor: structure, function, and evolution of a family business. Journal of Interferon & Cytokine Research 19:1069–1098
MordechaiE.,
KonN.,
HendersonE. E.,
SuhadolnikR. J.1995; Activation of the interferon-inducible enzymes, 2′,5′-oligoadenylate synthetase and PKR by human T-cell leukemia virus type I Rex-response element. Virology 206:913–922
MoriS.,
JewettA.,
CavalcantiM.,
Murakami-MoriK.,
NakamuraS.,
BonavidaB.1998; Differential regulation of human NK cell-associated gene expression following activation by IL-2, IFN-alpha and PMA/ionomycin. International Journal of Oncology 12:1165–1170
MossmanK.,
UptonC.,
BullerR. M. L.,
McFaddenG.1995; Species specificity of ectromelia virus and vaccinia interferon-γ binding proteins. Virology 208:762–769
MullerM.,
LaxtonC.,
BriscoeJ.,
SchindlerC.,
ImprotaT.,
DarnellJ. E.Jr,
StarkG. R.,
KerrI. M.1993; Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-α and -γ signal transduction pathways. EMBO Journal 12:4221–4228
MullerU.,
SteinhoffU.,
ReisL. F.,
HemmiS.,
PavlovicJ.,
ZinkernagelR. M.,
AguetM.1994; Functional role of type I and type II interferons in antiviral defense. Science 264:1918–1921
MurphyT. L.,
ClevelandM. G.,
KuleszaP.,
MagramJ.,
MurphyK. M.1995; Regulation of interleukin 12 p40 expression through an NF-kappa B half-site. Molecular and Cellular Biology 15:5258–5267
NakaT.,
NarazakiM.,
HirataM.,
MatsumotoT.,
MinamotoS.,
AonoA.,
NishimotoN.,
KajitaT.,
TagaT.,
YoshizakiK.,
AkiraS.,
KishimotoT.1997; Structure and function of a new STAT-induced STAT inhibitor. Nature 387:924–929
NguyenH.,
LinR.,
HiscottJ.1997; Activation of multiple growth regulatory genes following inducible expression of IRF-1 or IRF/RelA fusion proteins. Oncogene 15:1425–1435
NilsenT. W.,
BaglioniC.1979; Mechanism for discrimination between viral and host mRNA in interferon-treated cells. Proceedings of the National Academy of Sciences USA: 76:2600–2604
NunezR.1999; Revision of the functional analysis and structural features of immortalized dendritic cell lines derived from mice lacking both type I and type II interferon receptors. Immunology Letters 68:173–186
OffermannM. K.,
ZimringJ.,
MellitsK. H.,
HaganM. K.,
ShawR.,
MedfordR. M.,
MathewsM.,
GoodbournS.,
JagusR.1995; Activation of the double-stranded-RNA-activated protein kinase and induction of vascular cell adhesion molecule-1 by poly(I).poly(C) in endothelial cells. European Journal of Biochemistry 232:28–36
OgasawaraK.,
HidaS.,
AzimiN.,
TagayaY.,
SatoT.,
Yokochi-FukudaT.,
WaldmannT. A.,
TaniguchiT.,
TakiS.1998; Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 391:700–703
OkamuraH.,
KashiwamuraS.,
TsutsuiH.,
YoshimotoT.,
NakanishiK.1998; Regulation of interferon-gamma production by IL-12 and IL-18. Current Opinion in Immunology 10:259–264
PattersonJ. B.,
ThomisD. C.,
HansS. L.,
SamuelC. E.1995; Mechanism of interferon action: double-stranded RNA-specific adenosine deaminase from human cells is inducible by alpha and gamma interferons. Virology 210:508–511
PavlovicJ.,
ZurcherT.,
HallerO.,
StaeheliP.1990; Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. Journal of Virology 64:3370–3375
PavlovicJ.,
HallerO.,
StaeheliP.1992; Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. Journal of Virology 66:2564–2569
PenixL. A.,
SweetserM. T.,
WeaverW. M.,
HoefflerJ. P.,
KerppolaT. K.,
WilsonC. B.1996; The proximal regulatory element of the interferon-gamma promoter mediates selective expression in T cells. Journal of Biological Chemistry 271:31964–31972
PineR.1992; Constitutive expression of an ISGF2/IRF-1 transgene leads to interferon-independent activation of interferon-inducible genes and resistance to virus infection. Journal of Virology 66:4470–4478
PiskurichJ. F.,
LinhoffM. W.,
WangY.,
TingJ. P.1999; Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor beta. Molecular and Cellular Biology 19:431–440
PowellP. P.,
DixonL. K.,
ParkhouseR. M.1996; An IκB homolog encoded by African swine fever virus provides a novel mechanism for downregulation of proinflammatory cytokine responses in host macrophages. Journal of Virology 70:8527–8533
QiuY.,
KrugR. M.1994; The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A). Journal of Virology 68:2425–2432
QureshiS. J.,
LeungS.,
KerrI. M.,
StarkG. R.,
DarnellJ. E.Jr1996; Function of Stat2 protein in transcriptional activation by alpha interferon. Molecular and Cellular Biology 16:288–293
RamanaC. V.,
GrammatikakisN.,
ChernovM.,
NguyenH.,
GohK. C.,
WilliamsB. R.,
StarkG. R.2000; Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways. EMBO Journal 19:263–272
ReisL. F. L.,
HaradaH.,
WolchokJ. D.,
TaniguchiT.,
VilcekJ.1992; Critical role of a common transcription factor, IRF-1, in the regulation of IFN-β and IFN-inducible genes. EMBO Journal 11:185–193
RivasC.,
GilJ.,
MelkovaZ.,
EstebanM.,
Diaz-GuerraM.1998; Vaccinia virus E3L protein is an inhibitor of the interferon (IFN)-induced 2–5A synthetase enzyme. Virology 243:406–414
RojasR.,
RomanJ.,
TorresA.,
RamirezR.,
CarracedoJ.,
LopezR.,
GarciaJ. M.,
MartinC.,
PintadoO.1996; Inhibition of apoptotic cell death in B-CLL by interferon gamma correlates with clinical stage. Leukemia 10:1782–1788
RosmurducO.,
SirmaH.,
SoussanP.,
GordienE.,
LebonP.,
HorisbergerM.,
BréchotC.,
KremsdorfD.1999; Inhibition of interferon-inducible MxA protein expression by hepatitis B virus capsid protein. Journal of General Virology 80:1253–1262
RousseauV.,
CremerI.,
LauretE.,
RiviereI.,
AguetM.,
De MaeyerE.1995; Antiviral activity of autocrine interferon-beta requires the presence of a functional interferon type I receptor. Journal of Interferon and Cytokine Research 15:785–789
RoyS.,
KatzeM. G.,
ParkinN. T.,
EderyI.,
HovanessianA. G.,
SonenbergN.1990; Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science 247:1216–1219
RysieckiG.,
GewertD. R.,
WilliamsB. R.1989; Constitutive expression of a 2′,5′-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression. Journal of Interferon Research 9:649–657
SakatsumeM.,
IgarashiK.,
WinestockK. D.,
GarottaG.,
LarnerA. C.,
FinbloomD. S.1995; The Jak kinases differentially associate with the alpha and beta (accessory factor) chains of the interferon gamma receptor to form a functional receptor unit capable of activating STAT transcription factors. Journal of Biological Chemistry 270:17528–17534
SalkowskiC. A.,
KopydlowskiK.,
BlancoJ.,
CodyM. J.,
McNallyR.,
VogelS. N.1999; IL-12 is dysregulated in macrophages from IRF-1 and IRF-2 knockout mice. Journal of Immunology 163:1529–1536
SatoM.,
TanakaN.,
HataN.,
OdaE.,
TaniguchiT.1998a; Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene. FEBS Letters 425:112–116
SatoM.,
HataN.,
AsagiriM.,
NakayaT.,
TaniguchiT.,
TanakaN.1998b; Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Letters 441:106–110
SchaferS. L.,
LinR.,
MooreP. A.,
HiscottJ.,
PithaP. M.1998; Regulation of type I interferon gene expression by interferon regulatory factor-3. Journal of Biological Chemistry 273:2714–2720
SchindlerC.,
FuX.-Y.,
ImprotaT.,
AebersoldR.,
DarnellJ. E.Jr1992; Proteins of transcription factor ISGF-3: one gene encodes the 91- and 84-kDa proteins that are activated by interferon α. Proceedings of the National Academy of Sciences, USA 89:7836–7839
Schneider-SchauliesS.,
Schneider-SchauliesJ.,
SchusterA.,
BayerM.,
PavlovicJ.,
ter MeulenV.1994; Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells. Journal of Virology 68:6910–6917
SekimotoT.,
NakajimaK.,
TachibanaT.,
HiranoT.,
YonedaY.1996; Interferon-gamma-dependent nuclear import of Stat1 is mediated by the GTPase activity of Ran/TC4. Journal of Biological Chemistry 271:31017–31020
SharpT. V.,
SchwemmleM.,
JeffreyI.,
LaingK.,
MellorH.,
ProudC. G.,
HilseK.,
ClemensM. J.1993; Comparative analysis of the regulation of the interferon-inducible protein kinase PKR by Epstein–Barr virus RNAs EBER-1 and EBER-2 and adenovirus VAI RNA. Nucleic Acids Research 21:4483–4490
SharpT. V.,
MoonanF.,
RomashkoA.,
JoshiB.,
BarberG. N.,
JagusR.1998; The vaccinia virus E3L gene product interacts with both the regulatory and the substrate binding regions of PKR: implications for PKR autoregulation. Virology 250:302–315
SharpT. V.,
RaineD. A.,
GewertD. R.,
JoshiB.,
JagusR.,
ClemensM. J.1999; Activation of the interferon-inducible (2′–5′) oligoadenylate synthetase by the Epstein–Barr virus RNA, EBER-1. Virology 257:303–313
ShuaiK.,
StarkG. R.,
KerrI. M.,
DarnellJ. E.Jr1993; A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science 261:1744–1746
ShuaiK.,
HorvathC. M.,
HuangL. H.,
QureshiS. A.,
CowburnD.,
DarnellJ. E.Jr1994; Interferon activation of the transcription factor Stat91 involves dimerization through SH2–phosphotyrosyl peptide interactions. Cell 76:821–828
SilvermanR. H.1997; 2–5A-dependent RNase L: a regulated endoribonuclease in the interferon system. In Ribonucleases: Structure and Function pp 515–551 Edited by
D’AlessioG.,
RiordanJ. F.
New York: Academic Press;
SilvermanR. H.,
CirinoN. M.1997; RNA decay by the interferon-regulated 2–5A system as a host defense against viruses. In mRNA Metabolism and Post-transcriptional Gene Regulation pp 295–309 Edited by
HartfordJ. B.,
MorrisD. R.
New York: Wiley–Liss Inc;
SinghS. M.,
YanagawaH.,
HanibuchiM.,
MikiT.,
OkamuraH.,
SoneS.2000; Augmentation by interleukin-18 of MHC-nonrestricted killer activity of human peripheral blood mononuclear cells in response to interleukin-12. International Journal of Immunopharmacology 22:35–43
SnapperC. M.,
PeschelC.,
PaulW. E.1988; IFN-gamma stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide. Journal of Immunology 140:2121–2127
SnapperC. M.,
McIntyreT. M.,
MandlerR.,
PecanhaL. M.,
FinkelmanF. D.,
LeesA.,
MondJ. J.1992; Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens. Journal of Experimental Medicine 175:1367–1371
SrivastavaS. P.,
KumarK. U.,
KaufmanR. J.1998; Phosphorylation of eukaryotic translation initiation factor 2 mediates apoptosis in response to activation of the double-stranded RNA-dependent protein kinase. Journal of Biological Chemistry 273:2416–2423
StaeheliP.,
GrobR.,
MeierE.,
SutcliffeJ. G.,
HallerO.1988; Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Molecular and Cellular Biology 8:4518–4523
StarkG. R.,
KerrI. M.,
WilliamsB. R. G.,
SilvermanR. H.,
SchreiberR. D.1998; How cells respond to interferons. Annual Review of Biochemistry 67:227–264
StarrR.,
WillsonT. A.,
VineyE. M.,
MurrayL. J. L.,
RaynerJ. R.,
JenkinsB. J.,
GondaT. J.,
AlexanderW. S.,
MetcalfD.,
NicolaN. A.,
HiltonD. J.1997; A family of cytokine-inducible inhibitors of signalling. Nature 387:917–921
StrandenA. M.,
StaeheliP.,
PavlovicJ.1993; Function of the mouse Mx1 protein is inhibited by overexpression of the PB2 protein of influenza virus. Virology 197:642–651
SubramaniamP. S.,
JohnsonH. M.1997; A role for the cyclin-dependent kinase inhibitor p21 in the G1 cell cycle arrest mediated by the type I interferons. Journal of Interferon and Cytokine Research 17:11–15
SubramaniamP. S.,
CruzP. E.,
HobeikaA. C.,
JohnsonH. M.1998; Type I interferon induction of the Cdk-inhibitor p21WAF1 is accompanied by ordered G1 arrest, differentiation and apoptosis of the Daudi B-cell line. Oncogene 16:1885–1890
SymonsJ. A.,
AlcamiA.,
SmithG. L.1995; Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81:551–560
TakaokaA.,
TanakaN.,
MitaniY.,
MiyazakiT.,
FujiiH.,
SatoM.,
KovarikP.,
DeckerT.,
SchlessingerJ.,
TaniguchiT.1999; Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFN-γ, but not IFN-α, signaling. EMBO Journal 18:2480–2488
TakizawaT.,
OhashiK.,
NakanishiY.1996; Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection. Journal of Virology 70:8128–8132
TanS. L.,
KatzeM. G.1998; Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase. Journal of Interferon and Cytokine Research 18:757–766
TanS. L.,
KatzeM. G.1999; The emerging role of the interferon-induced PKR protein kinase as an apoptotic effector: a new face of death?Journal of. Interferon and Cytokine Research 19:543–554
TanakaN.,
SatoM.,
LamphierM. S.,
NozawaH.,
OdaE.,
NoguchiS.,
SchreiberR. D.,
TsujimotoY.,
TaniguchiT.1998; Type I interferons are essential mediators of apoptotic death in virally infected cells. Genes and Cells 3:29–37
TayC. H.,
YuL. Y.,
KumarV.,
MasonL.,
OrtaldoJ. R.,
WelshR. M.1999; The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections. Journal of Immunology 162:718–726
TaylorD. R.,
ShiS. T.,
RomanoP. R.,
BarberG. N.,
LaiM. M.1999; Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285:107–110
TominagaK.,
YoshimotoT.,
TorigoeK.,
KurimotoM.,
MatsuiK.,
HadaT.,
OkamuraH.,
NakanishiK.2000; IL-12 synergizes with IL-18 or IL-1β for IFN-γ production from human T cells. International Immunology 12:151–160
TrinchieriG.1995; Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annual Review of Immunology 13:251–276
TrowsdaleJ.,
HansonI.,
MockridgeI.,
BeckS.,
TownsendA.,
KellyA.1990; Sequences encoded in the class II region of the MHC related to the ‘ABC’ superfamily of transporters. Nature 348:741–744
van den BroekM. F.,
MullerU.,
HuangS.,
AguetM.,
ZinkernagelR. M.1995a; Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. Journal of Virology 69:4792–4796
van den BroekM. F.,
MullerU.,
HuangS.,
ZinkernagelR. M.,
AguetM.1995b; Immune defence in mice lacking type I and/or type II interferon receptors. Immunology Reviews 148:5–18
VealsS. A.,
SchindlerC.,
LeonardD.,
FuX. Y.,
AebersoldR.,
DarnellJ. E.Jr,
LevyD. E.1992; Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins. Molecular and Cellular Biology 12:3315–3324
VilcekJ.,
SenG.1996; Interferons and other cytokines. InFields Virology pp 375–399 Edited by
FieldsB. N.,
KnipeD. M.,
HowleyP. M.
Philadelphia: Lippincott–Raven;
VisvanathanK. V.,
GoodbournS.1989; Double-stranded RNA activates binding of NF-κB to an inducible element in the human β-interferon promoter. EMBO Journal 8:1129–1138
WatanabeN.,
SakakibaraJ.,
HovanessianA. G.,
TaniguchiT.,
FujitaT.1991; Activation of IFN-β element by IRF-1 requires a post-translational event in addition to IRF-1 synthesis. Nucleic Acids Research 19:4421–4428
WatheletM. G.,
LinC. H.,
ParekhB. S.,
RoncoL. V.,
HowleyP. M.,
ManiatisT.1998; Virus infection induces the assembly of coordinately activated transcription factors on the IFN-β enhancer in vivo. Molecular Cell 1:507–518
WeihuaX.,
RamanujamS.,
LindnerD. J.,
KudaravalliR. D.,
FreundR.,
KalvakolanuD. V.1998; The polyoma virus T antigen interferes with interferon-inducible gene expression. Proceedings of the National Academy of Sciences, USA 95:1085–1090
WenZ.,
ZhongZ.,
DarnellJ. E.1995; Maximal activation of transcription by STAT1 and STAT3 requires both tyrosine and serine phosphorylation. Cell 82:241–250
WhittenT. M.,
QuetsA. T.,
SchloemerR. H.1991; Identification of the hepatitis B virus factor that inhibits expression of the beta interferon gene. Journal of Virology 65:4699–4704
WongA. H.,
TamN. W.,
YangY. L.,
CuddihyA. R.,
LiS.,
KirchhoffS.,
HauserH.,
DeckerT.,
KoromilasA. E.1997; Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways. EMBO Journal 16:1291–1304
XuX.,
FuX. Y.,
PlateJ.,
ChongA. S.1998; IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression. Cancer Research 58:2832–2837
YanH.,
KrishnanK.,
GreenlundA. C.,
GuptaS.,
LimJ. T. E.,
SchreiberR. D.,
SchindlerC. W.,
KrolewskiJ. J.1996; Phosphorylated interferon-α receptor 1 subunit (IFNaR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein. EMBO Journal 15:1064–1074
YangY.-L.,
ReisL. F. L.,
PavlovicJ.,
AguzziA.,
SchaferR.,
KumarA.,
WilliamsB. R. G.,
AguetM.,
WeissmannC.1995; Deficient signalling in mice devoid of double-stranded RNA-dependent protein kinase, PKR. EMBO Journal 14:6095–6106
YeowW. S.,
AuW. C.,
JuangY. T.,
FieldsC. D.,
DentC. L.,
GewertD. R.,
PithaP. M.2000; Reconstitution of virus-mediated expression of interferon-alpha genes in human fibroblast cells by ectopic interferon regulatory factor-7. Journal of Biological Chemistry 275:6313–6320
YeungM. C.,
LiuJ.,
LauA. S.1996; An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells. Proceedings of the National Academy of Sciences USA: 93:12451–12455
YokooJ.,
GotohB.,
KomatsuT.,
TakeuchiK.,
MiyadaiT.1999; Replication-incompetent Sendai virus can suppress the antiviral action of type I interferon. Archives of Virology 144:1043–1055
YokosawaN.,
KubotaT.,
FujiiN.1998; Poor induction of interferon-induced 2′,5′-oligoadenylate synthetase (2–5 AS) in cells persistently infected with mumps virus is caused by decrease of STAT-1α. Archives of Virology 143:1985–1992
YoneyamaM.,
SuharaW.,
FukuharaY.,
FukudaM.,
NishidaE.,
FujitaT.1998; Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO Journal 17:1087–1095
YoshimotoT.,
TakedaK.,
TanakaT.,
OhkusuK.,
KashiwamuraS.,
OkamuraH.,
AkiraS.,
NakanishiK.1998; IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. Journal of Immunology 161:3400–3407
Zamanian-DaryoushM.,
MogensenT. H.,
DiDonatoJ. A.,
WilliamsB. R.2000; NF-κB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-κB-inducing kinase and IκB kinase. Molecular and Cellular Biology 20:1278–1290
ZhangJ. J.,
VinkemeierU.,
GuW.,
ChakravartiD.,
HorvathC. M.,
DarnellJ. E.Jr1996; Two contact regions between Stat1 and CBP/p300 in interferon-γ signaling. Proceedings of the National Academy of Sciences, USA 93:15092–15096
ZhangF.,
WangD. Z.,
BoothbyM.,
PenixL.,
FlavellR. A.,
AuneT. M.1998a; Regulation of the activity of IFN-gamma promoter elements during Th cell differentiation. Journal of Immunology 161:6105–6112
ZhangX.,
SunS.,
HwangI.,
ToughD. F.,
SprentJ.1998c; Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 8:591–599
ZhouA.,
ParanjapeJ. M.,
DerS. D.,
WilliamsB. R.,
SilvermanR. H.1999; Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. Virology 258:435–440